The Evolution of Redo Liver Transplantation Over 35 Years

Author:

Kaldas Fady M.1,Horwitz Julian K.1,Noguchi Daisuke1,Korayem Islam M.1,Markovic Daniela2,Ebaid Samer1,Agopian Vatche G.1,Yersiz Hasan1,Saab Sammy3,Han Steven B.3,El Kabany Mohamad M.3,Choi Gina3,Shetty Akshay3,Singh Jasleen3,Wray Christopher4,Barjaktarvic Igor5,Farmer Douglas G.1,Busuttil Ronald W.1

Affiliation:

1. Department of Surgery, Division of Liver and Pancreas Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, CA

2. Department of Biomathematics, David Geffen School of Medicine at UCLA, Los Angeles, CA

3. Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

4. Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

5. Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

Abstract

Objective: To examine liver retransplantation (ReLT) over 35 years at a single center. Background: Despite the durability of liver transplantation (LT), graft failure affects up to 40% of LT recipients. Methods: All adult ReLTs from 1984 to 2021 were analyzed. Comparisons were made between ReLTs in the pre versus post-model for end-stage liver disease (MELD) eras and between ReLTs and primary-LTs in the modern era. Multivariate analysis was used for prognostic modeling. Results: Six hundred fifty-four ReLTs were performed in 590 recipients. There were 372 pre-MELD ReLTs and 282 post-MELD ReLTs. Of the ReLT recipients, 89% had one previous LT, whereas 11% had ≥2. Primary nonfunction was the most common indication in the pre-MELD era (33%) versus recurrent disease (24%) in the post-MELD era. Post-MELD ReLT recipients were older (53 vs 48, P = 0.001), had higher MELD scores (35 vs 31, P = 0.01), and had more comorbidities. However, post-MELD ReLT patients had superior 1, 5, and 10-year survival compared with pre-MELD ReLT (75%, 60%, and 43% vs 53%, 43%, and 35%, respectively, P < 0.001) and lower in-hospital mortality and rejection rates. Notably, in the post-MELD era, the MELD score did not affect survival. We identified the following risk factors for early mortality (≤12 months after ReLT): coronary artery disease, obesity, ventilatory support, older recipient age, and longer pre-ReLT hospital stay. Conclusions: This represents the largest single-center ReLT report to date. Despite the increased acuity and complexity of ReLT patients, post-MELD era outcomes have improved. With careful patient selection, these results support the efficacy and survival benefit of ReLT in an acuity-based allocation environment.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Rejection in Liver Transplantation Recipients;Journal of Clinical and Experimental Hepatology;2024-07

2. Retransplantation in Living Donor Liver Transplantation;Transplantation;2024-05-21

3. Untersuchungen zur Leberretransplantation;Allgemein- und Viszeralchirurgie up2date;2024-03

4. Untersuchungen zur Leberretransplantation;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2023-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3